FDA 483 - Dr. Reddy's Laboratories Limited CTO VI - June 07, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Dr. Reddy's Laboratories Limited CTO - Unit VI in Pydibhimavaram, India, revealed significant deficiencies across multiple areas of pharmaceutical manufacturing. The firm failed to adequately validate analytical methods for Active Pharmaceutical Ingredients (APIs) and ensure manufacturing processes remained in a validated state. Furthermore, out-of-specification investigations lacked scientific support and effective corrective actions, and the quality unit released API batches without completing all required tests.
ID · 0f8e7b96-e996-493f-abbe-c0625f1f10e5